DTIL - Precision BioSciences, Inc. -  [ ]

Ticker Details
Precision BioSciences, Inc.
IPO Date: May 25, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $170.56M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.24 | 3.66%
Avg Daily Range (30 D): $0.25 | 4.48%
Avg Daily Range (90 D): $0.17 | 3.46%
Institutional Daily Volume
Avg Daily Volume: .19M
Avg Daily Volume (30 D): .29M
Avg Daily Volume (90 D): .22M
Trade Size
Avg Trade Size (Sh.): 55
Avg Trade Size (Sh.) (30 D): 76
Avg Trade Size (Sh.) (90 D): 84
Institutional Trades
Total Institutional Trades: 326
Avg Institutional Trade: $1.4M
Avg Institutional Trade (30 D): $.82M
Avg Institutional Trade (90 D): $1.23M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.54M
Avg Closing Trade (30 D): $.82M
Avg Closing Trade (90 D): $1.23M
Avg Closing Volume: 9.61K
 
News
Jan 22, 2026 @ 9:56 AM
Genome Editing Market Forecast to Reach $23.6 Bill...
Source: Researchandmarkets.Com
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Sep 10, 2024 @ 9:00 AM
Global Genetic Engineering Market Size To Worth US...
Source: Spherical Insights & Consulting
Sep 10, 2024 @ 8:51 AM
Gene Editing Therapeutics Market Forecast 2024-202...
Source: Researchandmarkets.Com
May 29, 2024 @ 1:55 PM
Does Precision BioSciences (DTIL) Have the Potenti...
Source: Zacks Equity Research
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-3.56 $2.58 $-3.56
Diluted EPS $-3.56 $2.58 $-3.56
Revenue $34.26M $34.2M $34.26M
Gross Profit
Net Income / Loss $-45.72M $20.13M $-45.72M
Operating Income / Loss $-52.15M $12.51M $-52.15M
Cost of Revenue
Net Cash Flow $28.69M $65.94M $28.69M
PE Ratio    
Splits
Feb 14, 2024 1:30